Status:

RECRUITING

PET-study on the Role of the Reward System in Weight Loss After Bariatric Surgery

Lead Sponsor:

University Medical Center Groningen

Conditions:

Obesity

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

Bariatric surgery (BS) is currently the most effective treatment in severe obesity. However, a considerable percentage of patients undergoing BS fail to lose sufficient weight or regain weight after i...

Eligibility Criteria

Inclusion

  • Bariatric surgery 24-36 months prior to the study
  • Adult (over 18y old)
  • Mentally capable to understand the consequences of the procedure and make his or her own choice without coercion
  • Able to undergo PET and MRI, according to the investigator's assessment
  • Native speaking
  • Able to participate in follow-up
  • Written informed consent

Exclusion

  • Presence of a DSM-IV axis 1 disorder
  • The use of drugs that bind to dopamine D2/3 receptors, including various classes of antipsychotics and antidepressants
  • History of stroke, brain tumor, Parkinson's Disease or dementia
  • History of head trauma with loss of consciousness
  • Alcohol or substance abuse in the last 6 months
  • Alcohol consumption 24h prior to PET scanning
  • Smoking or other forms of nicotine intake 12 hours prior to PET scanning
  • Use of anorectic drugs in the last 6 months
  • Current pregnancy
  • Medication for Diabetes Mellitus
  • Claustrophobia
  • The presence of implanted metal objects of the type which may concentrate radiofrequency fields or cause tissue damage from twisting in a magnetic field (such as certain implanted devices, shrapnel, ocular metal shavings)
  • Patients with a bodyweight \> 200kg will be excluded to ensure the maximum load of the camera bed of the PET-scanner (227 kg) is not exceeded.

Key Trial Info

Start Date :

December 1 2022

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

December 31 2024

Estimated Enrollment :

30 Patients enrolled

Trial Details

Trial ID

NCT05359887

Start Date

December 1 2022

End Date

December 31 2024

Last Update

May 14 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

MCL

Leeuwarden, Netherlands